Review Article
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Table 1
Patient-specific pluripotent stem cells in neurological diseases.
| Disease | Disease gene/molecular defect | Generated neural cell type | Disease-specific genotype/phenotype in iPSCs and/or generated neural cells | Reference |
| SMA (type 1) | SMN | Motor neuron | Decreased neuronal survival |
Ebert et al. [91] | FD | IKBKAP | NCPC | Impaired neuronal differentiation and migration | Lee et al. [92] | HD | Huntingtin | Striatal neuron | Enhanced caspase activity and neurotoxicity | Zhang et al. [93] | | | NSC | Upon growth factor deprivation in iPSC-derived NSCs 72 CAG repeats in iPSCs | Park et al. [82] | FA | Frataxin | — | GAA·TTC triplet repeat instability in iPSCs | Ku et al. [94] | ALS | Multifactorial | Motor neuron | L144F polymorphism of SOD1 gene | Dimos et al. [95] | PD | Multifactorial | vmDopaminergic neuron | Not evaluated | Cooper et al. [96] | | | Dopaminergic neuron | Not evaluated | Soldner et al. [62] | | | | Not evaluated | Park et al. [82] | AS | UBE3A | Neuron/astrocyte | UBE3A repression | Chamberlain et al. [97] | PWS | Imprinting defect | Neuron/astrocyte-like | Decreased SNORD116 expression in iPSCs | Yang et al. [98] | | | — | Methylation imprint in iPSCs | Chamberlain et al. [97] | DS | Trisomy 21 | — | Decreased tumor formation by iPSCs | Baek et al. [99] | | | | Trisomy 21 in iPSCs | Park et al. [82] | BMD | Dystrophin | — | Not shown | Park et al. [82] | DMD | Dystrophin | — | Deletion of exons 45–52 in iPSCs | Park et al. [82] | | | — | Deletion of exons 4–43 in iPSCs | Kazuki et al. [100] |
|
|
Amyotrophic lateral sclerosis (ALS), Angelman syndrome (AS), Becker muscular dystrophy (BMD), Down syndrome (DS), Duchenne muscular dystrophy (DMD), familial dysautonomia (FD), Friedreich's ataxia (FA), Huntington disease (HD), I-κ-B kinase complex-associated protein (IKBKAP), neural crest precursor cell (NCPC), neural stem cell (NSC), Parkinson disease (PD), Prader-Willi syndrome (PWS), small nucleolar RNA (snoRNA) HBII-85 (SNORD116), survival motor neuron (SMN), superoxide dismutase 1 (SOD1), spinal muscular atrophy (SMA), ubiquitin protein ligase E3A (UBE3A), and ventral midbrain (vm).
|